Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

636 ARTÍCULOS , VIENDO DEL 196 AL 210

Reflections on 50 Years of Neuroscience Nursing: Movement Disorders, Neuromuscular Disease, and Multiple Sclerosis

Woods JM.

J Neurosci Nurs. 2018 Feb;50(1):5-12. doi: 10.1097/JNN.0000000000000327.

Neuropathology of autonomic dysfunction in synucleinopathies

Coon EA, Cutsforth-Gregory JK, Benarroch EE.

Mov Disord. 2018 Mar;33(3):349-358. doi: 10.1002/mds.27186. Epub 2018 Jan 3.

The emerging role of Rab GTPases in the pathogenesis of Parkinson's disease

Gao Y, Wilson GR, Stephenson SEM, Bozaoglu K, Farrer MJ, Lockhart PJ.

Mov Disord. 2018 Feb;33(2):196-207. doi: 10.1002/mds.27270. Epub 2018 Jan 9.

Interaction between caffeine and polymorphisms of glutamate ionotropic receptor NMDA type subunit 2A (GRIN2A) and cytochrome P450 1A2 (CYP1A2) on Parkinson's disease risk

Kim IY, O'Reilly ÉJ, Hughes KC, Gao X, Schwarzschild MA, McCullough ML, Hannan MT, Betensky RA, Ascherio A.

Mov Disord. 2018 Mar;33(3):414-420. doi: 10.1002/mds.27279. Epub 2018 Jan 10.

The History of Movement Disorder Brain Surgery

Lunsford LD, Niranjan A.

Prog Neurol Surg. 2018;33:1-12. doi: 10.1159/000480717. Epub 2018 Jan 12.

Magnetic Resonance-Guided High Intensity Focused Ultrasound for Treating Movement Disorders

Kim YG, Kweon EJ, Chang WS, Jung HH, Chang JW.

Prog Neurol Surg. 2018;33:120-134. doi: 10.1159/000481080. Epub 2018 Jan 12.

Deep Brain Stimulation of the Subthalamic Nucleus and Globus Pallidus for Parkinson's Disease

Lee PS, Crammond DJ, Richardson RM.

Prog Neurol Surg. 2018;33:207-221. doi: 10.1159/000481105. Epub 2018 Jan 12.

Drug Delivery for Movement Disorders

Barua N, Gill S.

Prog Neurol Surg. 2018;33:243-252. doi: 10.1159/000481108. Epub 2018 Jan 12.

Gene Therapy for Parkinson's Disease

Sudhakar V, Richardson RM.

Prog Neurol Surg. 2018;33:253-264. doi: 10.1159/000481109. Epub 2018 Jan 12.

Mitochondrial function and autophagy: integrating proteotoxic, redox, and metabolic stress in Parkinson's disease

Zhang J, Culp ML, Craver JG, Darley-Usmar V.

J Neurochem. 2018 Mar;144(6):691-709. doi: 10.1111/jnc.14308. Epub 2018 Feb 14.

Proline-rich transmembrane protein 2-negative paroxysmal kinesigenic dyskinesia: Clinical and genetic analyses of 163 patients

Tian WT, Huang XJ, Mao X, Liu Q, Liu XL, Zeng S, Guo XN, Shen JY, Xu YQ, Tang HD, Yin XM, Zhang M, Tang WG, Liu XR, Tang BS, Chen SD, Cao L.

Mov Disord. 2018 Mar;33(3):459-467. doi: 10.1002/mds.27274. Epub 2018 Jan 22.

Alternative Splicing of Alpha- and Beta-Synuclein Genes Plays Differential Roles in Synucleinopathies

Gámez-Valero A, Beyer K.

Genes (Basel). 2018 Jan 25;9(2):63. doi: 10.3390/genes9020063.

Features of GBA-associated Parkinson's disease at presentation in the UK Tracking Parkinson's study

Malek N, Weil RS, Bresner C, Lawton MA, Grosset KA, Tan M, Bajaj N, Barker RA, Burn DJ, Foltynie T, Hardy J, Wood NW, Ben-Shlomo Y, Williams NW, Grosset DG, Morris HR; PRoBaND clinical consortium.

J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):702-709. doi: 10.1136/jnnp-2017-317348. Epub 2018 Jan 29.

99mTc-TRODAT-1 SPECT/CT imaging as a complementary biomarker in the diagnosis of parkinsonian syndromes

Mittal BR, Sood A, Shukla J, Vatsa R, Bhusari P, Shree R, Mehta S, Goyal M, Modi M.

Nucl Med Commun. 2018 Apr;39(4):312-318. doi: 10.1097/MNM.0000000000000802.

Bilateral subthalamic deep brain stimulation initial impact on nonmotor and motor symptoms in Parkinson's disease: An open prospective single institution study

Kurcova S, Bardon J, Vastik M, Vecerkova M, Frolova M, Hvizdosova L, Nevrly M, Mensikova K, Otruba P, Krahulik D, Kurca E, Sivak S, Zapletalova J, Kanovsky P.

Medicine (Baltimore). 2018 Feb;97(5):e9750. doi: 10.1097/MD.0000000000009750.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias